Kathleen Dungan, MD
Enriched profileProfessor of Medicine, Division of Endocrinology, Diabetes & Metabolism; Associate Director of Clinical Services and Director of Endocrine Clinical Trials · The Ohio State University Wexner Medical Center
Kathleen Dungan is Professor of Medicine, Division of Endocrinology, Diabetes & Metabolism; Associate Director of Clinical Services and Director of Endocrine Clinical Trials at The Ohio State University Wexner Medical Center. OpenAlex indexes 252 publications with 10,705 citations (h-index 34); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Kathleen Dungan, MD, is Professor of Medicine, Division of Endocrinology, Diabetes & Metabolism at The Ohio State University Wexner Medical Center. The public record shows 252 publications with 10,705 citations (h-index 34), centered on Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes Treatment and Management. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 6 companies, 3 NIH-funded awards (2008–2026).
- Most recent indexed publication: 2026 · Journal of diabetes science and technology
- Top research focus: Diabetes Management and Research
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 25 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 72.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Continuous Glucose Monitoring Following Hospital Discharge
Sponsor: Kathleen Dungan
- Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer
Sponsor: Ohio State University Comprehensive Cancer Center
Industry payments
Updated 14 Oct 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20257 payments
- Abbott LaboratoriesProgram year20251 payment
- Dexcom, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
84.4%Insulin Analog28.5%Tresiba Flextouch U-10019%Lantus Solostar14%Tresiba Flextouch U-20012%Novolog Flexpen10%Fiasp Flextouch10%Basaglar Kwikpen U-1007%Humalog Kwikpen U-2005%Lyumjev Kwikpen U-1005%Toujeo Solostar4%Insulin Lispro4%Novolog4%Humalog Kwikpen U-1004%Admelog Solostar3%Part D<11 patientsGLP-1 receptor agonist27.8%Trulicity32%Mounjaro31%Ozempic29%Rybelsus8%Part D<11 patients+ 6 more classes in this area
Cardiovascular
10.4%Statin8.1%Rosuvastatin Calcium44%Atorvastatin Calcium44%Simvastatin11%Part D<11 patientsACE inhibitor1.3%Lisinopril100%Part D<11 patients+ 1 more class in this area
Hormonal (systemic)
5.3%l-Thyroxine5.3%Levothyroxine Sodium79%Synthroid21%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
3 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Epidemiology and Pathophysiology of Acute Pancreatitis-related Diabetes Mellitus
Ohio State University
FY2026$520,000U01DK127388 - Epidemiology and Pathophysiology of Acute Pancreatitis-related Diabetes Mellitus
Ohio State University
FY2025$492,500U01DK127388 - Intensive glycemic control for congestive heart failure exacerbation
Ohio State University
FY2012$142,533K23DK080891
Congress activity
Updated 14 Oct 2026
11 congress contributions (2018–2025) across ADA per OpenAlex. The most recent:
- 2033-LB: Real-World, Patient-Reported Outcomes among Individuals with Type 2 Diabetes Using Continuous Glucose Monitoring following Hospital Discharge
ADA Scientific Sessions
ADA2025Co-authorLate-breaking - 643-P: A Model-Based Evaluation of Glycemic and Weight Changes When Switching from Semaglutide to Additional Doses of Dulaglutide
ADA Scientific Sessions
ADA2021Co-authorPoster - 660-P: Greater Proportions of Subjects Achieved Composite Endpoints with Once-Weekly Semaglutide vs. Comparators in SUSTAIN Trials
ADA Scientific Sessions
ADA2021Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Continuous Glucose Monitoring in the Intensive Care Unit: A Multicenter, Retrospective Hospital-Based Analysis.
Journal of diabetes science and technology
Article2026 - Effect of Continuous Glucose Monitoring Following Hospital Discharge of Patients With Type 2 Diabetes.
Journal of the Endocrine Society
Article2026 - Comparative Effectiveness of Hybrid Closed-Loop Automated Insulin Delivery Systems Among Patients with Type 1 Diabetes.
Journal of diabetes science and technology
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Stress hyperglycaemia1,415 citations2009
- 03
- 05Glucose variability and mortality in patients with sepsis*437 citations2008
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/kathleen-dungan-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Kathleen-Dungan-2147901450
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - ResearchGate
researchgate.net/scientific-contributions/Kathleen-M-Dungan-38613540
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/OSUWexMed/status/1886145566159118418
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu ↗
- MPH
The Ohio State University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardi-oh.org ↗
Editorial & leadership roles
journal and society appointments- Associate Director of Clinical Services
Division of Endocrinology, Diabetes & Metabolism, OSU
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardi-oh.org ↗ - Director of Endocrine Clinical Trials
OSU Division of Endocrinology, Diabetes & Metabolism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardi-oh.org ↗ - Associate Editor
Endotext
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org ↗ - Program Director
eDiabetes Review
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org ↗ - Planning committee member
American Diabetes Association Scientific Sessions and Endocrine Society Hypoglycemia Prevention Initiative / Clinical Endocrine Update
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.osu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardi-oh.org ↗
Secondary affiliations
appointments beyond the home institution- Cardi-OH (Ohio Cardiovascular and Diabetes Health Collaborative)
contributing faculty/expert
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardi-oh.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiometabolichealth.org ↗
- Pri-Med
faculty
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pri-med.com ↗
Media & interviews
press, podcasts and appearances- Guest on "Diabetes Care 'On Air'" podcast (American Diabetes Association)
discussing her article on hyperglycemia during acute pancreatitis and the DREAM study
2026provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetesjournals.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardi-oh.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Raphael Pollock, MD, PhD
The Ohio State University Wexner Medical Center
John Kissel, MD
The Ohio State University Wexner Medical Center
Douglas Scharre, MD
The Ohio State University Wexner Medical Center
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine